Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

7,184 total articles

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Reports Fourth Quarter Results

Nortech Systems Incorporated reported a profitable fourth quarter for 2025, achieving net income of $0.9 million compared to a loss in the prior year quarter. The company saw increased net sales to $30.3 million and significant improvement in EBITDA, reflecting successful strategic restructuring and operational efficiencies. Nortech also secured $1…

Auburn National Bancorporation, Inc. Elects New Director

Auburn National Bancorporation, Inc. Elects New Director

Auburn National Bancorporation, Inc. has expanded its Board of Directors to include Jeff Evans, who brings over 30 years of experience in property management, construction, and real estate. Evans is also nominated for reelection at the upcoming Annual Meeting of Shareholders. The company and its subsidiary, AuburnBank, operate primarily in East Ala…

Fortuna files Form 40-F, Annual Report

Fortuna files Form 40-F, Annual Report

Fortuna Mining Corp., a Canadian precious metals mining company, has filed its annual report on Form 40-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The filing includes audited consolidated financial statements, management's discussion and analysis, and an annual information form. The company oper…

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company focused on therapies for gout and progressive kidney disease, announced a delay in the effective date of its 1-for-5 share consolidation from March 27, 2026, to April 6, 2026. The consolidation remains subject to necessary approvals from the TSX Venture Exchange and Nasdaq Stock …

Abundia Global Impact Group Sets Annual Meeting of Stockholders and Provides Update on Its Annual Filings

Abundia Global Impact Group Sets Annual Meeting of Stockholders and Provides Update on Its Annual Filings

Abundia Global Impact Group, Inc. announced its 2026 Annual Meeting of Stockholders to be held on May 14, 2026, and provided an update on its annual filings. The company disclosed that its audited financial statements for fiscal year 2025 included a going concern qualification from its independent auditor, highlighting uncertainties regarding its a…

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria

Disc Medicine has completed enrollment of the Phase 3 APOLLO trial for bitopertin, an investigational oral treatment for erythropoietic protoporphyria (EPP). The study was expanded from 150 to 183 participants due to high demand. Results are expected in Q4 2026, with subsequent regulatory engagement aimed at FDA approval potentially by mid-2027. Th…

Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.

Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.

CVB Financial Corp. and Heritage Commerce Corp. announced shareholder approval for their proposed merger. The transaction, pending regulatory approvals, is expected to close in the second quarter of 2026. The merger aims to combine two strong California-based banking organizations to enhance service offerings and achieve operational synergies.

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical, a clinical-stage biopharmaceutical company, announced positive results from their first-in-human LIBERATE-1 study and preclinical data for their semaglutide implant (NPM-139), demonstrating sustained drug exposure and over 20% weight loss for one year. The company plans to initiate a Phase 1 clinical study in mid-2026 with anticipat…

AmpliTech Group Reports Fiscal Year 2025 Results With 165% Revenue Growth and Strategic Expansion Into 5G Infrastructure

AmpliTech Group Reports Fiscal Year 2025 Results With 165% Revenue Growth and Strategic Expansion Into 5G Infrastructure

AmpliTech Group reported a stellar fiscal year 2025 with revenue reaching $25.2 million, marking a 165% increase from the prior year, driven by strong demand for its 5G-related low noise amplifier and block products. The company strategically invested in expanding its 5G product lines and penetration into Tier 1 network operators despite gross marg…

NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

Nanobiotix, a late-clinical stage biotechnology company specializing in nanoparticle-based cancer treatments and other diseases, announced it will report its financial results for Q4 and full year 2025 on March 31, 2026. The results will be followed by a conference call and webcast on April 1, 2026, where company executives will provide a business …

Stifel Reports February 2026 Operating Data

Stifel Reports February 2026 Operating Data

Stifel Financial Corp. reported operating data for February 2026 highlighting a 12% year-over-year increase in total client assets (excluding assets sold), 16% growth in fee-based client assets, and substantial treasury deposit growth driven by venture banking. The company completed the sale of Stifel Independent Advisors in early February 2026. De…

Acuity Inc. Declares Quarterly Dividend

Acuity Inc. Declares Quarterly Dividend

Acuity Inc., a leading industrial technology company listed on NYSE under the ticker AYI, declared a quarterly dividend of 20 cents per share payable on May 1, 2026 to shareholders of record as of April 17, 2026. The company continues to focus on growth through innovation in lighting and intelligent space technologies.

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Vehicles, Powertrains, and Energy Storage

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Vehicles, Powertrains, and Energy Storage

Xos, Inc. reported its fourth quarter and full-year 2025 financial results, achieving its third consecutive quarter of positive operating and free cash flow. The company expanded its platform with first production powertrains delivered to Blue Bird school buses and advanced its energy storage technology with significant gigawatt-hour charging miles…

ROC Access Face1 Wins “Best in Biometrics” at ISC West 2026 Security Industry Association New Products and Solutions Awards

ROC Access Face1 Wins “Best in Biometrics” at ISC West 2026 Security Industry Association New Products and Solutions Awards

Rank One Computing Corporation (ROC) announced that its ROC Access Face1 biometric reader has won the 'Best in Biometrics' award at the 2026 Security Industry Association New Products and Solutions Awards at ISC West. The product's innovative design and integration of biometric verification, video analytics, and intelligent access demonstrate ROC's…

Vroom Announces Fourth Quarter and Full Year 2025 Results

Vroom Announces Fourth Quarter and Full Year 2025 Results

Vroom, Inc. announced its Q4 and full-year 2025 financial results highlighting a $129.3 million improvement in net loss compared to 2024 and strengthened liquidity with $48.7 million total available. The company emerged from Chapter 11 in January 2025 with fresh start accounting impacting comparability. Despite improvements, adjusted net loss remai…

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

CapsoVision, Inc. reported a 13% increase in Q4 2025 revenue and 15% growth for the full year compared to 2024, driven by increased sales of its CapsoCam Plus capsule endoscopy products. The company advanced its AI-assisted imaging technology with a 510(k) FDA submission, developed new CMOS sensors under an agreement with Canon, and raised $14 mill…

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Beyond Air, Inc. announced that CEO Steve Lisi has resigned and Robert Goodman, the current Chief Commercial Officer, has been appointed as CEO effective immediately. The change aims to accelerate market adoption and scale commercial operations of their LungFit PH medical device. Mr. Goodman brings extensive leadership experience in healthcare and …

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Rani Therapeutics announced its Q4 and full-year 2025 financial results along with significant corporate developments. The company secured a collaboration and licensing agreement with Chugai Pharmaceutical valued up to $1.085 billion, successfully completed a $60.3 million private placement, and initiated a Phase 1 clinical trial for RT-114, an ora…